CFM
RMD icon

Catalyst Funds Management’s ResMed RMD Stock Holding History

Catalyst Funds Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+1,600
New +$332K 0.02% 494
2026
Q1 		– Sell
-10,859
Closed -$2.62M – 694
2025
Q4 		$2.62M Sell
10,859
-8,400
-44% -$2.15M 0.61% 34
2025
Q3 		$5.27M Buy
+19,259
New +$5.26M 0.8% 21
2024
Q4 		– Sell
-800
Closed -$195K – 1077
2024
Q3 		$195K Buy
800
+100
+14% +$22.3K 0.04% 299
2024
Q2 		$134K Buy
+700
New +$142K 0.04% 246

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Catalyst Funds Management's RMD Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in ResMed (RMD) in Q2 2026: 1,600 shares worth $312K. The stake represents 0.02% of the portfolio and ranks #494 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in RMD as recently as Q4 2025.

Catalyst Funds Management first reported a position in RMD in Q2 2024 and has held it in 5 quarters since. The position peaked at $5.27M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Catalyst Funds Management held 1,600 shares of ResMed worth $312K as of Q2 2026.
  • ResMed was a new Catalyst Funds Management position in Q2 2026.
  • ResMed made up 0.02% of Catalyst Funds Management's portfolio in Q2 2026, its #494 holding.
  • Catalyst Funds Management first reported a position in ResMed in Q2 2024 and has held it in 5 quarters since.
  • Catalyst Funds Management's ResMed position peaked at $5.27M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.